Abstract:Background & Aims: As important virological markers, serum hepatitis B surface antigen (HBsAg) and hepatitis B virus (HBV) DNA levels show large fluctuations among chronic hepatitis B patients. The aim of this study was to reveal the potential impact and mechanisms of amino acid substitutions in small hepatitis B surface proteins (SHBs) on serum HBsAg and HBV DNA levels.Methods: Serum samples from 230 untreated chronic hepatitis B patients with genotype C HBV were analyzed in terms of HBV DNA levels, serological markers of HBV infection and SHBs sequences. In vitro functional analysis of the identified SHBs mutants was performed.Results: Among 230 SHBs sequences, there were 39 (16.96%) sequences with no mutation detected (wild-type) and 191 (83.04%) with single or multiple mutations. SHBs consist of 226 amino acids, of which 104 (46.02%) had mutations in our study. Some mutations (e.g., sE2G, sL21S, sR24K, sT47A/K, sC69stop (sC69*), sL95W, sL98V, and sG145R) negatively correlated with serum HBsAg levels. HBsAg and HBV DNA levels from this group of patients had a positive correlation (r = 0.61, p<0.001). In vitro analysis showed that these mutations reduced extracellular HBsAg and HBV DNA levels by restricting virion secretion and antibody binding capacity. Virion secretion could be rescued for sE2G, sC69*, and sG145R by co-expression of wild-type HBsAg.Conclusion: The serum HBsAg levels were lower in untreated CHB patients with novel SHBs mutations outside the major antigenic region than those without mutations. Underlying mechanisms include impairment of virion secretion and lower binding affinity to antibodies used for HBsAg measurements.Lay summary: The hepatitis B surface antigen (HBsAg) is a major viral protein of the hepatitis B virus (HBV) secreted into patient blood serum and its quantification value serves as an important marker for the evaluation of chronic HBV infection and antiviral response. We found a few new amino acid substitutions in HBsAg associated with lower serum HBsAg and HBV DNA levels. These different substitutions might impair virion secretion, change the ability of HBsAg to bind to antibodies, or impact HBV replication. These could all result in decreased detectable levels of serum HBsAg. The factors affecting circulating HBsAg level and HBsAg detection are varied and caution is needed when interpreting clinical significance of serum HBsAg levels. Clinical trial number: NCT01088009. (C) 2016 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

The Thr to Met Substitution of Amino Acid 118 in Hepatitis B Virus Surface Antigen Escapes from Immune-Assay-based Screening of Blood Donors.

A new vaccine escape mutant of hepatitis B virus causes occult infection.

[Functional Analysis of Hepatitis B Virus Immune Escape Mutants with Insertion Mutations in the Surface Antigen].

Amino Acid Substitutions at Positions 122 and 145 of Hepatitis B Virus Surface Antigen (hbsag) Determine the Antigenicity and Immunogenicity of HBsAg and InfluenceIn VivoHBsAg Clearance

Biological Significance of Amino Acid Substitutions in Hepatitis B Surface Antigen (hbsag) for Glycosylation, Secretion, Antigenicity and Immunogenicity of HBsAg and Hepatitis B Virus Replication

Mutant hepatitis B virus surface antigens (HBsAg) are immunogenic but may have a changed specificity.

PP-102 The study of the CD4+CD25+treg induced by human plasmacytoid dendritic cells from chronic hepatitis B in vitro

Reduced Antigenicity of Naturally Occurring Hepatitis B Surface Antigen Variants with Substitutions at the Amino Acid Residue 126.

Effects of Amino Acid Substitutions in Hepatitis B Virus Surface Protein on Virion Secretion, Antigenicity, HBsAg and Viral DNA.

Hepatitis B virus Surface gene mutants in immunoprophylaxis-failed infants from Southern China.

Higher Detection Rates of Amino Acid Substitutions in HBV Reverse Transcriptase/surface Protein Overlapping Sequence is Correlated with Lower Serum HBV DNA and HBsAg Levels in HBeAg-positive Chronic Hepatitis B Patients with Subgenotype B2

Mutations in hepatitis B virus DNA from patients with coexisting HBsAg and anti-HBs.

A Novel Insertion in the Hepatitis B Virus Surface Protein Leading to Hyperglycosylation Causes Diagnostic and Immune Escape

A Mutant Hbs Antigen (Hbsag)183-191 Epitope Elicits Specific Cytotoxic T Lymphocytes in Acute Hepatitis B Patients

Antigenicity of major hydrophilic region Ⅱ of hepatitis B virus surface antigen

The amino Acid residues at positions 120 to 123 are crucial for the antigenicity of hepatitis B surface antigen.

Effect of Mutation Within the ‘a’ Determinant on the Antigenicity of Hepatitis B Surface Antigen

Influence of Mutations in Hepatitis B Virus Surface Protein on Viral Antigenicity and Phenotype in Occult HBV Strains from Blood Donors.

Detection of Hepatitis B Virus Genome with Mutations Outside the Major Hydrophilic Region in the Surface Antigen Isolated from Patients with Coexisting HBsAg and Anti-HBs

Hepatitis B Virus (HBV) Vaccine-Induced Escape Mutants of HBV S Gene among Children from Qidong Area, China.

Impact of hepatitis B virus surface protein mutations on the diagnosis of occult hepatitis B virus infection